221 related articles for article (PubMed ID: 19574417)
1. Improving the biomarker pipeline to develop and evaluate cancer screening tests.
Baker SG
J Natl Cancer Inst; 2009 Aug; 101(16):1116-9. PubMed ID: 19574417
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of serum-based cancer biomarkers: a brief review from a clinical and computational viewpoint.
Yotsukura S; Mamitsuka H
Crit Rev Oncol Hematol; 2015 Feb; 93(2):103-15. PubMed ID: 25459666
[TBL] [Abstract][Full Text] [Related]
3. Cancer screening: a mathematical model relating secreted blood biomarker levels to tumor sizes.
Lutz AM; Willmann JK; Cochran FV; Ray P; Gambhir SS
PLoS Med; 2008 Aug; 5(8):e170. PubMed ID: 18715113
[TBL] [Abstract][Full Text] [Related]
4. Cancer biomarkers: can we turn recent failures into success?
Diamandis EP
J Natl Cancer Inst; 2010 Oct; 102(19):1462-7. PubMed ID: 20705936
[TBL] [Abstract][Full Text] [Related]
5. Serum ceruloplasmin as a diagnostic marker of cancer.
Senra Varela A; Lopez Saez JJ; Quintela Senra D
Cancer Lett; 1997 Dec; 121(2):139-45. PubMed ID: 9570351
[TBL] [Abstract][Full Text] [Related]
6. Early reporting for cancer screening trials.
Baker SG; Kramer BS; Prorok PC
J Med Screen; 2008; 15(3):122-9. PubMed ID: 18927094
[TBL] [Abstract][Full Text] [Related]
7. [Clinical studies beyond the German Drug Law. Studies for evaluating diagnostic tests].
Abel U; Jensen K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):425-32. PubMed ID: 19326057
[TBL] [Abstract][Full Text] [Related]
8. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.
Mok SC; Chao J; Skates S; Wong K; Yiu GK; Muto MG; Berkowitz RS; Cramer DW
J Natl Cancer Inst; 2001 Oct; 93(19):1458-64. PubMed ID: 11584061
[TBL] [Abstract][Full Text] [Related]
9. [Clinical use and evolution of circulating biomarkers in the era of personalized oncology: From protein markers to bioclinical scores].
Perrier A; Hainaut P; Lamy PJ; Guenoun A; Nguyen DP; Guerber F; Troalen F; Denis JA; Boissan M
Bull Cancer; 2022 Feb; 109(2):151-169. PubMed ID: 35012767
[TBL] [Abstract][Full Text] [Related]
10. Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers.
Wilhelmsen M; Christensen IJ; Rasmussen L; Jørgensen LN; Madsen MR; Vilandt J; Hillig T; Klaerke M; Nielsen KT; Laurberg S; Brünner N; Gawel S; Yang X; Davis G; Heijboer A; Martens F; Nielsen HJ
Int J Cancer; 2017 Mar; 140(6):1436-1446. PubMed ID: 27935033
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive Detection of Colorectal Carcinomas Using Serum Protein Biomarkers.
Ivancic MM; Megna BW; Sverchkov Y; Craven M; Reichelderfer M; Pickhardt PJ; Sussman MR; Kennedy GD
J Surg Res; 2020 Feb; 246():160-169. PubMed ID: 31586890
[TBL] [Abstract][Full Text] [Related]
12. [Liquid biopsy: a possible approach for cancer screening].
Thierry AR; Tanos R
Med Sci (Paris); 2018 Oct; 34(10):824-832. PubMed ID: 30451677
[TBL] [Abstract][Full Text] [Related]
13. Proteomic applications for the early detection of cancer.
Wulfkuhle JD; Liotta LA; Petricoin EF
Nat Rev Cancer; 2003 Apr; 3(4):267-75. PubMed ID: 12671665
[TBL] [Abstract][Full Text] [Related]
14. Emerging blood-based biomarkers for detection of gastric cancer.
Kalniņa Z; Meistere I; Kikuste I; Tolmanis I; Zayakin P; Linē A
World J Gastroenterol; 2015 Nov; 21(41):11636-53. PubMed ID: 26556992
[TBL] [Abstract][Full Text] [Related]
15. [Screening for asymptomatic cancers?].
Jordan B
Med Sci (Paris); 2018 Apr; 34(4):363-365. PubMed ID: 29658481
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumour cells and circulating endothelial cells as biomarkers in oncology.
Strijbos MH
Acta Clin Belg; 2011; 66(5):332-6. PubMed ID: 22145267
[TBL] [Abstract][Full Text] [Related]
17. Cancer screening through a multi-analyte serum biomarker panel during health check-up examinations: Results from a 12-year experience.
Wen YH; Chang PY; Hsu CM; Wang HY; Chiu CT; Lu JJ
Clin Chim Acta; 2015 Oct; 450():273-6. PubMed ID: 26344337
[TBL] [Abstract][Full Text] [Related]
18. [Biomarker screening for early detection of cancer].
Wiedemann GJ
Dtsch Med Wochenschr; 2013 Jan; 138(1-2):43-5. PubMed ID: 23250696
[TBL] [Abstract][Full Text] [Related]
19. The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?
Diamandis EP
BMC Med; 2012 Aug; 10():87. PubMed ID: 22876833
[TBL] [Abstract][Full Text] [Related]
20. Empirical evaluation demonstrated importance of validating biomarkers for early detection of cancer in screening settings to limit the number of false-positive findings.
Chen H; Knebel P; Brenner H
J Clin Epidemiol; 2016 Jul; 75():108-14. PubMed ID: 26836253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
